RESUMO
The experiments described in this report were designed to study the effects of danazol on matrix metalloproteinases in the rat uterus. Proteinases were analyzed by zymography in gels copolymerized with either gelatin or transferrin. There were no apparent effects of danazol on proteinases from rat uteri when analyzed in gelatin gels. However, in transferrin gels, not only did more bands appear in control samples but also there was a clear negative effect of danazol on the production of these proteinases. Similar results were obtained from uteri of ovariectomized rats. Again no differences were observed in gelatin gels but the control bands which appeared only on transferrin gels were missing in transferrin gels as a result of ovariectomy. These results indicate that there is an effect of estrogen on the synthesis of specific matrix metalloproteinases in the rat uterus and that these proteinases are only observed by zymography when gels are developed in transferrin but not collagen.
Assuntos
Danazol/farmacologia , Antagonistas de Estrogênios/farmacologia , Metaloproteinases da Matriz/metabolismo , Ovariectomia , Útero/enzimologia , Animais , Técnicas de Cultura , Modelos Animais de Doenças , Eletroforese em Gel de Ágar , Feminino , Metaloproteinases da Matriz/efeitos dos fármacos , Ratos , Ratos Sprague-Dawley , Valores de Referência , Sensibilidade e Especificidade , Útero/efeitos dos fármacosRESUMO
Synthesis and secretion of blood coagulation factor X was studied during incubations of hepatocytes prepared by perfusion of rat livers with collagenase. The apparent molecular weight of factor X isolated from the incubation medium was about 14,000 less than factor X isolated from rat plasma. The extracellular form of factor X was a two-chain polypeptide and the observed difference in molecular weight was reflected in the heavy chain. Since these properties were more characteristic of factor Xa than factor X, experiments were designed to determine if factor X activation occurred during the incubations. Clotting factor assays indicated that factor X secreted by hepatocytes was present as factor Xa. Also, when purified plasma factor X was added to incubations of hepatocytes the added factor X was converted to factor Xa. Plasma membranes prepared from isolated hepatocytes or from liver homogenates contained an enzyme that converted factor X to factor Xa in a calcium-dependent reaction. The results suggest that the activity is due to the presence of thromboplastin (tissue factor) and factor VII in the membrane preparations.
Assuntos
Membrana Celular/metabolismo , Fator X/metabolismo , Fator Xa/metabolismo , Fígado/metabolismo , Animais , Membrana Celular/enzimologia , Fígado/citologia , RatosRESUMO
14C-Labeled single-chain factor X prepared by vitamin K-dependent carboxylation in vitro was partially purified by adsorption to BaSO4 and chromatography on DEAE-Sephacel. Known activators of factor X were analyzed for their effect on the single-chain molecule. 14C-Labeled factor X antigens were recovered immunochemically from incubation mixtures and characterized by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Incubation with trypsin resulted in the generation of factor Xa clotting activity, and the 14C-labeled product migrated after reduction with an apparent molecular weight of 22,500 +/- 1500 (mean +/- 1 SD). The light chain produced by factor Xa was similar to that produced by trypsin (Mr 24,500 +/- 1500; mean +/- 1 SD). Incubation of single-chain factor X with factor VII and thromboplastin, factor IXa, or the factor X activating enzyme from Russell's viper venom gave a reducible product with a light chain of higher apparent molecular weight (Mr 37,000-38,000). Incubation with factor VII and thromboplastin also resulted in the generation of factor Xa clotting activity. Incubation of single-chain factor X with platelets resulted in the binding of about 20% of the 14C. The bound 14C-labeled factor X antigen released by freezing and thawing in the presence of EDTA was reduced to give a 14C-labeled polypeptide with Mr 31,000. Walker 256 tumor cells bound about 30% of the 14C. The bound material, after reduction, gave a 14C-labeled polypeptide with Mr 23,000.
Assuntos
Fator X/isolamento & purificação , Fígado/análise , Animais , Afinidade de Anticorpos , Especificidade de Anticorpos , Testes de Coagulação Sanguínea , Fenômenos Químicos , Química , Eletroforese em Gel de Poliacrilamida , Fator X/imunologia , Fator X/fisiologia , Imunoquímica , Masculino , Peso Molecular , Fragmentos de Peptídeos/análise , RatosRESUMO
Factor X in plasma is a gamma-carboxylated two-chain glycoprotein which, in activated form, plays a pivotal role in blood coagulation. We have utilized purified rat Factor X antibody, coupled to Sepharose, to isolate and characterize Factor X in rat liver, plasma, and hepatoma cells. Rat factor X is synthesized as a single chain precursor (Mr = 63,000). It is this form which undergoes vitamin K-dependent carboxylation in rat liver microsomes. Only after secretion is Factor X converted into its two-chain mature form. Single chain X synthesis and secretion in hepatoma cells is enhanced by vitamin K. The amount of single chain X secreted by these cells is one-half that of prothrombin. The NH2-terminal gamma-carboxylated fragments of prothrombin which induce prothrombin synthesis (Graves, C. B., Munns, T. W., Carlisle, T. L., Grant, G. A., and Strauss, A. W. (1981) Proc. Natl. Acad. Sci. U. S. A. 78, 4772-4776) also induce single chain X synthesis by hepatoma cells. We propose that synthesis of all vitamin K-dependent proteins may be regulated by this common control mechanism.
Assuntos
Fator X/biossíntese , Neoplasias Hepáticas Experimentais/metabolismo , Protrombina/fisiologia , Animais , Linhagem Celular , Eletroforese em Gel de Poliacrilamida , Fator X/isolamento & purificação , Fragmentos de Peptídeos/metabolismo , Ratos , Tunicamicina/farmacologia , Vitamina K/farmacologiaAssuntos
Anticoagulantes/farmacologia , Epóxido Hidrolases/antagonistas & inibidores , Hidroliases/antagonistas & inibidores , Fígado/enzimologia , Vitamina K/metabolismo , Animais , Cumarínicos/farmacologia , Cinética , Fígado/efeitos dos fármacos , Masculino , Naftoquinonas/farmacologia , Piridinas/farmacologia , Ratos , Varfarina/farmacologiaRESUMO
The separation of sufficient cis and trans forms of vitamin K for feeding and metabolic studies was accomplished on silica gel columns eluted with solvent containing n-butyl ether. The lack of biological activity of the cis isomer of phylloquinone was observed. The cis isomer was retained longer in liver, particularly in mitochondria, but had low retention in that portion of the endoplasmic reticulum isolated as the rough membrane fraction. The cis isomer of phylloquinone was a poor substrate for 2,3-epoxidation in vivo and in vitro. These data are consistent with the hypothesis that epoxidation of vitamin K is coupled to the biological activity of the vitamin, and that microsomes are the site of metabolism and function of vitamin K.
Assuntos
Fígado/metabolismo , Vitamina K 1/fisiologia , Animais , Éteres Cíclicos/metabolismo , Masculino , Microssomos Hepáticos/metabolismo , Oxirredutases/metabolismo , Protrombina/metabolismo , Ratos , Estereoisomerismo , Relação Estrutura-Atividade , Frações Subcelulares/metabolismo , Vitamina K 1/isolamento & purificaçãoAssuntos
Hormônios Esteroides Gonadais/farmacologia , Vitamina K 1/metabolismo , Deficiência de Vitamina K/metabolismo , Animais , Radioisótopos de Carbono , Castração , DDT/farmacologia , Estradiol/farmacologia , Éteres Cíclicos/metabolismo , Feminino , Hidrolases/metabolismo , Masculino , Metilcolantreno/farmacologia , Microssomos Hepáticos/enzimologia , Oxirredutases/metabolismo , Fenobarbital/farmacologia , Progesterona/farmacologia , Protrombina/metabolismo , Ratos , Fatores Sexuais , Testosterona/farmacologia , Fatores de Tempo , Deficiência de Vitamina K/enzimologiaRESUMO
The oxidation of phylloquinone to the 2,3-epoxide (by phylloquinone epoxidase) was studied in liver from control and warfarin-resistant rats. The reaction requires microsomal fraction, soluble protein, a heat-stable soluble factor and O(2). It is not inhibited by CO or CN(-). Epoxidase activity was stimulated if plasma prothrombin was lowered either by anticoagulants or the absence of vitamin K. The activity of the enzyme rapidly returned to normal values after the administration of vitamin K to hypoprothrombinaemic rats. These differences in the activity of the enzyme occur in the microsomal fraction and not the cytosol. A thrombin-generating polypeptide that accumulates in microsomal fraction of hypothrombinaemic rats correlated directly with epoxidase activity. These data support the view that enzymic interconversion of phylloquinone and its 2,3-epoxide participates in the biological activity of vitamin K.